{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis+%28RA%29&page=11", "query": { "condition": "Rheumatoid Arthritis (RA)", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 248, "total_pages": 25, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis+%28RA%29&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis+%28RA%29&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T03:59:59.594Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00966875", "title": "A Study in Patients With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "LY2439821", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 448, "start_date": "2009-08", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2016-05-26", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 37, "location_summary": "Peoria, Arizona • La Mesa, California • Palm Desert, California + 34 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "La Mesa", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Santa Maria", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00966875" }, { "nct_id": "NCT00106535", "title": "A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "tocilizumab [RoActemra/Actemra]", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1196, "start_date": "2005-01", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2014-02-06", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00106535" }, { "nct_id": "NCT00650455", "title": "Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "valdecoxib", "type": "DRUG" }, { "name": "naproxen", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 489, "start_date": "2003-02", "completion_date": "2005-01", "has_results": false, "last_update_posted_date": "2008-07-21", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Glendale, Arizona + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00650455" }, { "nct_id": "NCT02833350", "title": "Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "GDC-0853", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Folic Acid", "type": "DRUG" }, { "name": "MTX", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 578, "start_date": "2016-09-09", "completion_date": "2018-07-02", "has_results": true, "last_update_posted_date": "2020-06-12", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 23, "location_summary": "Anniston, Alabama • Glendale, Arizona • Covina, California + 18 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "El Cajon", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02833350" }, { "nct_id": "NCT02066389", "title": "A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Upadacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 300, "start_date": "2014-03-26", "completion_date": "2015-07-02", "has_results": true, "last_update_posted_date": "2021-07-30", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 12, "location_summary": "Hemet, California • DeBary, Florida • Venice, Florida + 9 more", "locations": [ { "city": "Hemet", "state": "California" }, { "city": "DeBary", "state": "Florida" }, { "city": "Venice", "state": "Florida" }, { "city": "Lawrenceville", "state": "Georgia" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02066389" }, { "nct_id": "NCT01500278", "title": "Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Certolizumab Pegol (CZP)", "type": "BIOLOGICAL" }, { "name": "Adalimumab (ADA)", "type": "BIOLOGICAL" }, { "name": "Methotrexate (MTX)", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "UCB Pharma SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 915, "start_date": "2011-12", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Tucson, Arizona + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01500278" }, { "nct_id": "NCT07258849", "title": "A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis (RA)" ], "interventions": [ { "name": "LY4213663", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 141, "start_date": "2025-12-02", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 9, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Clearwater, Florida + 6 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Cooper City", "state": "Florida" }, { "city": "Daytona Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07258849" }, { "nct_id": "NCT03616158", "title": "Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Lung Diseases" ], "interventions": [], "intervention_types": [], "sponsor": "National Jewish Health", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 340, "start_date": "2018-05-10", "completion_date": "2024-12-01", "has_results": false, "last_update_posted_date": "2019-06-06", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03616158" }, { "nct_id": "NCT01142726", "title": "Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Abatacept placebo", "type": "DRUG" }, { "name": "Methotrexate placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2010-12", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2016-01-14", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 15, "location_summary": "Huntsville, Alabama • Hot Springs, Arkansas • Sarasota, Florida + 12 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01142726" }, { "nct_id": "NCT00280917", "title": "Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "CF101", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Can-Fite BioPharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 254, "start_date": "2006-06", "completion_date": "2007-04", "has_results": true, "last_update_posted_date": "2023-09-18", "last_synced_at": "2026-10-14T03:59:59.594Z", "location_count": 5, "location_summary": "Peoria, Arizona • Albany, New York • Cleveland, Ohio + 2 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Albany", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Perrysburg", "state": "Ohio" }, { "city": "Sugar Land", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00280917" } ] }